X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Following a competitive auction process, Tolmar was selected as the winning bidder in the sale of JATENZO (testosterone undecanoate), and the sale was approved by the U.S. Bankruptcy Court for the District of Delaware.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Tolmar
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition October 27, 2022
Details:
JATENZO (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 18, 2022
Details:
JATENZO (testosterone undecanoate capsules; C-III), is the most prescribed FDA-approved softgel treatment with a safe delivery to help reach and keep normal testosterone levels.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 18, 2022
Details:
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 28, 2022
Details:
JATENZO (testosterone undecanoate) is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 09, 2022
Details:
CLAR-121 is combination of testosterone undecanoate (natural ligand for the androgen receptor and anastrozole delivered by a subcutaneous implant for treatment of AR-mediated inflammatory breast disease that predominantly affects women.
Lead Product(s): Testosterone Undecanoate,Anastrozole
Therapeutic Area: Immunology Product Name: CLAR-121
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 10, 2022
Details:
Jatenzo (testosterone undecanoate), is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 09, 2022
Details:
JATENZO (testosterone undecanoate) is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 28, 2022
Details:
Jatenzo (testosterone undecanoate) is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 19, 2022
Details:
JATENZO (testosterone undecanoate) is the first and only FDA-approved oral softgel for testosterone (T) replacement therapy in adult males who have deficient T due to certain medical conditions, for the treatment of adult hypogonadal men with chronic kidney disease.
Lead Product(s): Testosterone Undecanoate
Therapeutic Area: Endocrinology Product Name: Jatenzo
Highest Development Status: Phase IVProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 16, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
